Overall, 31 (11.74%) patients presented with prediabetes, 58 (21.97%) presented with diabetes mellitus type 2 treated with oral hypoglycemic medications, and 4 (1.52%) had diabetes mellitus type 2 treated with insulin. The gene discussed is INS; the disease is type 2 diabetes mellitus.